Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Puretech Health Plc ADR
(NQ:
PRTC
)
28.68
UNCHANGED
Streaming Delayed Price
Updated: 12:04 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Puretech Health Plc ADR
< Previous
1
2
3
4
5
Next >
PureTech to Present at the Jefferies Healthcare Conference
May 24, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week
May 09, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic
May 04, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Announces Annual Results for Year Ended December 31, 2022
April 28, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
April 25, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMID
April 17, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Health: Notice of Results
April 13, 2023
From
PureTech Health plc
Via
Business Wire
Royalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 Million
March 23, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million
March 23, 2023
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Barclays Global Healthcare Conference
March 01, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)
February 27, 2023
From
PureTech Health plc
Via
Business Wire
PureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum Depression
February 14, 2023
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the SVB Securities Global Biopharma Conference
February 01, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Provides End of Year Report on Key Progress
December 22, 2022
From
PureTech Health plc
Via
Business Wire
PureTech’s LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy Volunteers
December 19, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference
December 13, 2022
From
PureTech
Via
Business Wire
PureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual Meeting
December 12, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health Monitoring
December 09, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech’s Glyph™ Platform
November 30, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at Two Upcoming Investor Conferences
November 17, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Jefferies London Healthcare Conference
November 09, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Credit Suisse 31st Annual Healthcare Conference
November 01, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Morgan Stanley Global Healthcare Conference
September 08, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting Design of Dose-Ranging Trial in Idiopathic Pulmonary Fibrosis (IPF) at European Respiratory Society International Congress 2022
September 06, 2022
From
PureTech Health
Via
Business Wire
PureTech Health plc – Half-Year Report
August 25, 2022
From
PureTech
Via
Business Wire
PureTech Founded Entity Sonde Health Announces Multi-Year Partnership with Koye Pharmaceuticals
August 24, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Health: Notice of Half-Yearly Results
August 04, 2022
From
PureTech Health
Via
Business Wire
PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan
August 01, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate
July 14, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces Public Company Board of Director Nominees
July 11, 2022
From
PureTech Health plc
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.